Proact Q2 2023: Adjusted EBITA Better Than Expected - Redeye

Redeye retains its positive view of Proact following a strong Q2 report showing solid cost control and robust organic growth in recurring revenue. Management sees solid demand in most markets, although some are affected by macroeconomic uncertainty. We will likely raise our forecasts and Base Case somewhat.

Länk till analysen i sin helhet: https://www.redeye.se/research/921528/proact-q2-2023-adjusted-ebita-better-than-expected?utm_source=finwire&utm_medium=RSS